# Clinical Evaluation of the Combined Use of Apligraf® and the SNaP® Pressure Wound Therapy System

> **NCT01623882** · — · WITHDRAWN · sponsor: **KCI USA, Inc**

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01623882
- **Lead sponsor:** KCI USA, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-06
- **Primary completion:** 2014-06
- **Final completion:** 2015-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was terminated by Spiracur (original sponsor). Efforts were made to contact the PI/study team members, but were unsuccessful.
- **Last updated:** 2024-11-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01623882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01623882, "Clinical Evaluation of the Combined Use of Apligraf® and the SNaP® Pressure Wound Therapy System". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01623882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*